Biotricity, Inc.
BTCY
$0.11
$0.00-2.47%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.59% | 2.62% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.59% | 2.62% | |||
| Cost of Revenue | 15.66% | 4.54% | |||
| Gross Profit | 4.54% | 2.20% | |||
| SG&A Expenses | -14.82% | -5.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.26% | -1.80% | |||
| Operating Income | 57.54% | 61.03% | |||
| Income Before Tax | 54.79% | -3.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 54.79% | -3.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 54.79% | -3.79% | |||
| EBIT | 57.54% | 61.03% | |||
| EBITDA | 57.32% | 60.70% | |||
| EPS Basic | 61.78% | -43.94% | |||
| Normalized Basic EPS | 56.97% | -2.48% | |||
| EPS Diluted | 61.78% | -43.45% | |||
| Normalized Diluted EPS | 56.97% | -2.48% | |||
| Average Basic Shares Outstanding | 3.54% | 3.08% | |||
| Average Diluted Shares Outstanding | 3.54% | 3.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -1.21% | 0.05% | |||